What is AlterG?
Founded in Fremont, California, in 2005, AlterG specializes in developing innovative mobility enhancement products. These devices are designed to aid in physical therapy and athletic training, offering solutions for rehabilitation and performance improvement. The company's technology aims to provide controlled environments for patients and athletes to move more freely and safely, facilitating faster recovery and enhanced training outcomes. AlterG's commitment to advancing rehabilitation and training technologies positions it as a key player in the medical device sector.
How much funding has AlterG raised?
AlterG has raised a total of $55.3M across 8 funding rounds:
Series B
$8M
Debt
$2M
Series C
$10.3M
Debt
$15M
Debt
$3.5M
Unspecified
$6M
Debt
$8M
Series B (2009): $8M led by Versant Ventures and Red Planet Capital
Debt (2010): $2M supported by Versant Ventures
Series C (2012): $10.3M featuring Versant Ventures
Debt (2015): $15M backed by Oxford Finance
Debt (2017): $3.5M with participation from First West Capital and Siena Lending Group, LLC
Unspecified (2018): $6M led by Sorehsa AG, Leerink Revelation Partners, Versant Ventures, and Partner Ventures
Debt (2021): $8M supported by Cortland Credit Group
Key Investors in AlterG
Cortland Credit Group
Cortland Credit Group is a Canadian private debt asset manager that provides short-term senior-secured asset-based loans, focusing on diversified portfolios with overlooked credit assets for accredited investors.
Leerink Revelation Partners
Leerink Partners is an investment bank with deep sector knowledge in healthcare and life sciences, dedicated to assisting clients in achieving their strategic objectives.
Versant Ventures
Versant Ventures is a venture capital firm that partners with entrepreneurs to build and fund innovative biotechnology companies, with a strong track record in IPOs and M&A transactions.
What's next for AlterG?
The recent major strategic investment signals a new phase of growth and development for AlterG. This capital infusion is likely to be directed towards expanding its product line, enhancing its technological capabilities, and broadening its market reach. Given the enterprise-level nature of its total funding, AlterG appears poised for significant scaling, potentially exploring new applications for its core technology or entering adjacent markets. The company's strategic financing trajectory suggests a focus on sustained innovation and market leadership in the rehabilitation and athletic performance sectors.
See full AlterG company page
